alexa Pharmacokinetics And Pharmacodynamics Of Thymoquinone As A Novel Agent In Sepsis Management
ISSN: 0975-0851

Journal of Bioequivalence & Bioavailability
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

5th World Congress on Bioavailability and Bioequivalence Pharmaceutical R&D Summit
September 29-October 01, 2014 DoubleTree by Hilton Baltimore-BWI Airport, USA

Khalid M Alkharfy
ScientificTracks Abstracts: J Bioequiv Availab
DOI: 10.4172/0975-0851.S1.017
Abstract
S epsis or septic shock is a multiple organ failure syndrome and is one of the main causes of death in intensive care units. The induction of inflammation during sepsis is a complex biological cascade, which requires exhaustive therapeutic intervention. A series of experiments were designed to evaluate the effect of thymoquinone (TQ) treatment on a septic model and to elucidate the possible mechanism in the process. TQ significantly improved renal and hepatic functions alone and in combination with a nitric oxide inhibitor (L-NAME). TNF-α, IL-1α, IL-2 and IL-10 levels were significantly decreased with TQ and L-NAME treatments as compared with untreated animals. Vascular activity of isolated aorta of septic mice pretreated with TQ and/or L-NAME demonstrated an endothelial dependent contractile tone in contrast to relaxation in normal controls. Pharmacokinetic studies showed that THQ represents a compound with rapid elimination and relatively slower absorption after oral administration. Plasma concentration-time curves demonstrated a rapid poly exponential decline following intravenous dosing. These findings suggest that TQ has a strong potential for combating the sequel of the multiple organ failure syndrome of sepsis where modulations in inflammatory cytokines, nitric oxide production and vascular reactivity appear to be important mechanisms through which TQ exhibits its effect
Biography
Khalid M Alkharfy, PharmD, PhD is Professor at the College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. He is the Director of Pharmacokinetic/ Pharmacodynamic Research Laboratory, and a member of the Biomarkers Research Program at the university. Professor Alkharfy received a Bachelor of Pharmaceutical Sciences from King Saud University, a Doctorate of Pharmacy from University of Tennessee School of Pharmacy, and a Doctorate of Philosophy in Clinical Pharmaceutical Sciences from the University of Pittsburgh. Other current focus is drug discovery and development. The research in his laboratory utilizes contemporary methods of drug analysis coupled with molecular techniques in the pursuit of generating new information about the pathogenesis and treatment of diseases using both animal models and clinical patient samples
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version